Synthesis and pharmacological evaluation of peptide-mimetic protease-activated receptor-1 antagonists containing novel heterocyclic scaffolds
ABCD PBi
Synthesis and pharmacological evaluation of peptide-mimetic protease-activated receptor-1 antagonists containing novel heterocyclic scaffolds
Autor:
Severino
, Beatrice
;
Fiorino, Ferdinando
;
Perissutti, Elisa
;
Frecentese, Francesco
;
Cirino,
Giuseppe
;
Roviezzo, Fiorentina
;
Santagada, Vincenzo
;
Caliendo,
Giuseppe
Assuntos:
Animals
;
Antiplatelet effect
;
Aorta, Thoracic - drug effects
;
Aorta, Thoracic - physiology
;
Biological and medical sciences
;
Blood. Blood coagulation. Reticuloendothelial system
;
Heterocyclic Compounds - chemical synthesis
;
Heterocyclic Compounds - pharmacology
;
Humans
;
Indoles - chemical synthesis
;
Indoles - pharmacology
;
Male
;
Medical sciences
;
Molecular Mimicry
;
PAR-1
;
Peptides - chemical synthesis
;
Peptides - pharmacology
;
Peptidomimetic
;
Pharmacology. Drug treatments
;
Platelet Aggregation - drug effects
;
Protease Inhibitors - chemical synthesis
;
Protease Inhibitors - pharmacology
;
Rats
;
Rats, Wistar
;
Receptor, PAR-1 - antagonists & inhibitors
;
Thrombin
;
Vasoconstriction - drug effects
É parte de:
Bioorganic & medicinal chemistry, 2008-06, Vol.16 (11), p.6009-6020
Notas:
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição:
Here, we describe the synthesis and the pharmacological evaluation of novel PAR-1 peptide-mimetic antagonists characterized by the presence of new heterocyclic nuclei such as 2-methyl-indole (5- and 6-substituted) and 1,4-benzodiazepine moiety. Protease-activated receptor-1 (PAR-1) is a G-coupled receptor activated by α-thrombin and other proteases. In this paper we describe the synthesis and the pharmacological evaluation of novel peptide-mimetic antagonists (compounds 1– 16) characterized by the presence of new heterocyclic nuclei such as 2-methyl-indole (5- and 6-substituted) and 1,4-benzodiazepine moiety. The new derivatives, tested in order to evaluate their antagonist potency by using human platelet aggregation induced by PAR-1AP, resulted in some cases (compounds 1 and 4) more potent than the reference. The compounds, tested on aortic rings, confirmed the results obtained in the aggregation assay.
Editor:
Oxford: Elsevier Ltd
Idioma:
Inglês